ATE223379T1 - N-aryloxyethylaminderivate zur behandlung der depression - Google Patents
N-aryloxyethylaminderivate zur behandlung der depressionInfo
- Publication number
- ATE223379T1 ATE223379T1 AT99915318T AT99915318T ATE223379T1 AT E223379 T1 ATE223379 T1 AT E223379T1 AT 99915318 T AT99915318 T AT 99915318T AT 99915318 T AT99915318 T AT 99915318T AT E223379 T1 ATE223379 T1 AT E223379T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen
- halogen
- lower alkyl
- depression
- treatment
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 150000002431 hydrogen Chemical class 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5730798A | 1998-04-08 | 1998-04-08 | |
| PCT/US1999/007622 WO1999051576A1 (en) | 1998-04-08 | 1999-04-07 | N-aryloxyethylamine derivatives for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223379T1 true ATE223379T1 (de) | 2002-09-15 |
Family
ID=22009801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99915318T ATE223379T1 (de) | 1998-04-08 | 1999-04-07 | N-aryloxyethylaminderivate zur behandlung der depression |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1068184B1 (de) |
| JP (1) | JP2002510676A (de) |
| CN (1) | CN1160332C (de) |
| AT (1) | ATE223379T1 (de) |
| AU (1) | AU3386299A (de) |
| CA (1) | CA2327303A1 (de) |
| DE (1) | DE69902766T2 (de) |
| DK (1) | DK1068184T3 (de) |
| ES (1) | ES2182509T3 (de) |
| PT (1) | PT1068184E (de) |
| WO (1) | WO1999051576A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1414962A (zh) * | 1999-11-08 | 2003-04-30 | 惠氏公司 | 用于治疗中枢神经系统疾病的[(吲哚－3－基)－环烷基]－3－取代的氮杂环丁烷 |
| DE10006139A1 (de) * | 2000-02-11 | 2001-08-16 | Merck Patent Gmbh | Indol-3-yl-Derivate |
| JP2004531506A (ja) | 2001-03-29 | 2004-10-14 | ブリストル−マイヤーズ スクイブ カンパニー | 選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体 |
| US7041697B2 (en) * | 2002-09-12 | 2006-05-09 | Wyeth | Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| DE10305739A1 (de) * | 2003-02-11 | 2004-08-19 | Merck Patent Gmbh | Benzofuranderivate |
| DE10306941A1 (de) * | 2003-02-18 | 2004-08-26 | Merck Patent Gmbh | Benzofuranoxyethylamine |
| DE102006033109A1 (de) | 2006-07-18 | 2008-01-31 | Grünenthal GmbH | Substituierte Heteroaryl-Derivate |
| WO2009128088A2 (en) * | 2008-04-15 | 2009-10-22 | Shodhana Laboratories Limited | Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin |
| CN112358450A (zh) * | 2020-11-19 | 2021-02-12 | 南京艾康生物科技有限公司 | 一种4-(苄氧基)-2-甲基-1H-苯并[d]咪唑-6-羧酸的合成方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
| US3371098A (en) * | 1966-11-29 | 1968-02-27 | Philips Corp | 5- and 6-methoxy-3-(phenoxyethyl-aminoethyl)-indoles |
| DE2827874A1 (de) * | 1978-06-24 | 1980-02-07 | Merck Patent Gmbh | Indolalkylamine und verfahren zu ihrer herstellung |
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| US5124332A (en) * | 1991-01-28 | 1992-06-23 | Warner-Lambert Company | Substituted indoles as central nervous system agents |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| JPH05125024A (ja) * | 1991-11-05 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアリールオキシアルキルアミン誘導体又はその塩 |
| US5314896A (en) * | 1991-11-20 | 1994-05-24 | Warner-Lambert Company | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| JPH05255302A (ja) * | 1992-03-09 | 1993-10-05 | Yamanouchi Pharmaceut Co Ltd | 新規なクロマニルオキシアルキルアミン誘導体 |
| IT1271352B (it) * | 1993-04-08 | 1997-05-27 | Boehringer Ingelheim Italia | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale |
| US5436264A (en) * | 1993-08-19 | 1995-07-25 | Syntex (U.S.A.) Inc. | N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists |
| US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| JPH0940648A (ja) * | 1995-08-02 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | 新規な８−（２−アミノアルコキシ）キノリン誘導体 |
| AU4091697A (en) * | 1996-08-27 | 1998-03-19 | American Home Products Corporation | 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
| DE69713110T2 (de) * | 1996-08-27 | 2002-12-19 | Wyeth, Madison | 4-aminoethoxy-indolon-derivate |
-
1999
- 1999-04-07 CN CNB998068934A patent/CN1160332C/zh not_active Expired - Fee Related
- 1999-04-07 DK DK99915318T patent/DK1068184T3/da active
- 1999-04-07 ES ES99915318T patent/ES2182509T3/es not_active Expired - Lifetime
- 1999-04-07 PT PT99915318T patent/PT1068184E/pt unknown
- 1999-04-07 DE DE69902766T patent/DE69902766T2/de not_active Expired - Fee Related
- 1999-04-07 AT AT99915318T patent/ATE223379T1/de not_active IP Right Cessation
- 1999-04-07 EP EP99915318A patent/EP1068184B1/de not_active Expired - Lifetime
- 1999-04-07 WO PCT/US1999/007622 patent/WO1999051576A1/en not_active Ceased
- 1999-04-07 CA CA002327303A patent/CA2327303A1/en not_active Abandoned
- 1999-04-07 JP JP2000542297A patent/JP2002510676A/ja active Pending
- 1999-04-07 AU AU33862/99A patent/AU3386299A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002510676A (ja) | 2002-04-09 |
| CN1160332C (zh) | 2004-08-04 |
| ES2182509T3 (es) | 2003-03-01 |
| WO1999051576A1 (en) | 1999-10-14 |
| EP1068184A1 (de) | 2001-01-17 |
| DE69902766T2 (de) | 2003-02-06 |
| PT1068184E (pt) | 2002-12-31 |
| CA2327303A1 (en) | 1999-10-14 |
| DE69902766D1 (de) | 2002-10-10 |
| CN1303373A (zh) | 2001-07-11 |
| DK1068184T3 (da) | 2002-12-30 |
| AU3386299A (en) | 1999-10-25 |
| EP1068184B1 (de) | 2002-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE283268T1 (de) | 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission | |
| DE59600105D1 (de) | Verwendung von Adamantan-Derivaten zur Behandlung von Tinnitus | |
| ATE223379T1 (de) | N-aryloxyethylaminderivate zur behandlung der depression | |
| FI923540A0 (fi) | Arylalkylaminer och -amider med antikonvulsiva och nervskyddande egenskaper. | |
| DE69824476D1 (de) | Alkylene-Derivat, Anti-ulcus und antibakterielle Arzneimittel | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| ATE250027T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| ATE279925T1 (de) | Verwendung von halofuginon zur herstellung eines medikaments zur vorbeugung von neovaskularisation und zur behandlung bösartiger tumore | |
| DE69808669D1 (de) | 1-(adamantyl)amidine und ihre verwendung bei der behandlung von zuständen, die zusammenhängen mit abweichungen bei glutamatergischen übertragungen | |
| ATE181503T1 (de) | Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution | |
| DE69706355D1 (de) | Alkylendiamin-Derivate als Arzneimittel zur Behandlung von Geschwüren und Hemmung von Helicobacter pylori | |
| DE69619088D1 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
| NO994343L (no) | Anvendelse av 2,3,4,5 - tetrahydro- 1H-3-benzazepiner for fremstilling av en farmasöytisk blanding for behandlingen av soveuregelmessigheter | |
| ATE264840T1 (de) | Azetidincarboxamid-derivate zur behandlung von zns störungen | |
| ATE220665T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DE60005525D1 (de) | 2-aminotetraline zur behandlung von glaukom | |
| DE60000405D1 (de) | 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression | |
| ATE227718T1 (de) | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen | |
| DK0877612T3 (da) | Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser | |
| DE3770481D1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| ATE200673T1 (de) | 1,9-diazabicyclo(4.3.0)nona-3,8-dienderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1068184 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |